Toronto’s Imperial Capital has just closed its fifth fund and is hoping to funnel some of the $295 million it raised into middle-market healthcare companies in the U.S. and Canada.
The private equity firm focuses on acquiring and building healthcare, branded consumer product and business service companies with consistent cash flow and good growth opportunities.
It’s done four healthcare deals thus far, and Justin MacCormack, head of the firm’s healthcare practice, said it’s looking to do as much as it can in healthcare with the new fund. Specifically, he said the firm is interested in health IT and healthcare service businesses with very low reimbursement risks.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“Most of the companies we invest in are founder-owned, and typically they’re looking for someone to help their company get to the next level,” he said. “They tend to be companies that have a really good product or service but haven’t invested ahead of the curve.”
Imperial will typically put in place a seven-member board, work with the company to develop a strategic plan and implement incentive structures, he said.
Previous investments include health services company AIM Health Group, which it took private in 2011. In 2013, it sold two of the company’s three business lines to a strategic buyer, MacCormack said. It’s also invested in health IT firm STI Technologies Limited with money from the fifth fund.
[Image credit: Flickr user zzzack]
